Methodologic limitations or con- flicting findings of older studies present a

significant challenge to modern-day medical decision-making in many aspects of

thyroid neoplasia. Although they are not a specific focus of these guidelines, we
recognize that feasibility and cost considerations of various diagnostic and
therapeutic options